ACTIVE

PHENIX PROPERTY

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result691,5 k €+4 490,4 %over 1 year
Equity934,1 k €+44,5 %over 1 year

Identity

Source · BCE/KBO

PHENIX PROPERTY is a Public limited company incorporated in 1973. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Hoogstraten.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0413.676.987
Incorporation
30/10/1973
Legal form
Public limited company
Registered office
Sint Lenaartseweg 48
2320 Hoogstraten · FlandreSee on map
Contributed capital
199 250,00 €
Latest accounts
31/12/2025
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 20 filings

Trend over 20 financial years

20252024202320222021
Income statement
Revenue–––––
EBITDA872,2 k €-15,7 k €-6,1 k €-3,6 k €-3,9 k €
Operating result872,2 k €-15,7 k €-6,1 k €-3,6 k €-3,9 k €
Net result691,5 k €-15,8 k €-6,2 k €-3,8 k €-4 k €
Balance sheet
Equity934,1 k €646,7 k €662,4 k €668,6 k €672,4 k €
Total assets1,1 M €660,6 k €664,8 k €671,4 k €674,9 k €
Cash150 k €–––528,9 €
Debts194,3 k €13,9 k €2,4 k €2,9 k €2,5 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 5 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
VOXDALE0435.552.467Represented by René BEYERS
Directorsince 19/12/2023

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
KELA - Kempisch Laboratorium - Kela Laboratoria0403.835.645Represented by René Beyers
Managing director14/11/2017 → 19/12/2023
Philomena VAN PELT
Director20/06/2023 → 19/12/2023
Renatus BEYERS
Director20/06/2023 → 19/12/2023

Other companies at this address

Sint Lenaartseweg 48 2320 Hoogstraten
CompanyCBE no.
KELA - Kempisch Laboratorium - Kela Laboratoria● Active
0403.835.645
KELA VETERINARIA● Active
0412.402.527
Medicem● Active
0418.885.986
VOXDALE● Active
0435.552.467

Full financial information

Source · NBB
202520242023202220212020
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date01/07/202630/06/202503/07/202419/07/202320/07/202219/07/2021
General meeting02/06/202603/06/202504/06/202420/06/202324/06/202225/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202502/06/202601/07/2026DutchPDF
Full model31/12/202403/06/202530/06/2025DutchPDF
Full model31/12/202304/06/202403/07/2024DutchPDF
Full model31/12/202220/06/202319/07/2023DutchPDF
Full model31/12/202124/06/202220/07/2022DutchPDF
Full model31/12/202025/06/202119/07/2021DutchPDF
Full model31/12/201929/06/202003/07/2020DutchPDF
Full model31/12/201814/05/201915/07/2019DutchPDF
Full model31/12/201708/05/201808/06/2018DutchPDF
Full model31/12/201609/05/201701/06/2017DutchPDF
Full model31/12/201517/05/201627/06/2016DutchPDF
Full model31/12/201412/05/201524/06/2015DutchPDF
Full model31/07/201317/12/201314/01/2014DutchPDF
Full model31/07/201218/12/201208/01/2013DutchPDF
Full model31/07/201120/12/201122/02/2012DutchPDF
Full model31/07/201021/12/201007/01/2011DutchPDF
Full model31/07/200915/12/200902/02/2010DutchPDF
Full model31/12/200819/05/200923/06/2009DutchPDF
Full model31/12/200720/05/200811/06/2008DutchPDF
Full model31/12/200629/05/200721/06/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 5 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
VOXDALE0435.552.467Represented by René BEYERS
Directorsince 19/12/2023

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
KELA - Kempisch Laboratorium - Kela Laboratoria0403.835.645Represented by René Beyers
Managing director14/11/2017 → 19/12/2023
Philomena VAN PELT
Director20/06/2023 → 19/12/2023
Renatus BEYERS
Director20/06/2023 → 19/12/2023

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates12/01/2024
    DIVERSEN - DOEL - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING
    PDF
  • Mandates05/01/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates27/04/2021
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates20/12/2017
    HERBENOEMING EN BENOEMING BESTUURDERS
    PDF
  • Mandates14/06/2017
    BENOEMING COMMISSARIS
    PDF
  • Capital / shares06/07/2015
    VERKOOP AANDELEN
    PDF
  • Other30/07/2014
    WIJZIGING VAN DE STATUTEN — WIJZIGING BOEKJAAR — WIJZIGING
    PDF
  • Mandates22/01/2014
    HERBENOEMING BESTUURDERS - HERBENOEMING COMMISSARIS -
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings20 filings
Mandates
VOXDALE
KELA - Kempisch Laboratorium - Kela Laboratoria
Philomena VAN PELT
Renatus BEYERS
Renaat BEYERS
Roberta SLEDSENS
197319741975197619771978197919801981198219831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026
PHENIX PROPERTYPHENIX PHARMACEUTICALS
Sint Lenaartseweg 48, 2320 Hoogstraten
Director
Managing directorDirector
Director
DirectorManaging director
Managing director
Chairman of the board of directors
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Sint Lenaartseweg 48, 2320 HoogstratenCurrent
accounts 2021 → 2025
Accounts 2025 · 2026-00244447

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
PHENIX PROPERTYCurrent
accounts 2009 → 2025
Accounts 2025 · 2026-00244447
PHENIX PHARMACEUTICALS
accounts 2006 → 2008
Accounts 2008 · 2009-27500333

Events

  1. 2025
    Annual accounts 2025691,5 k €↑
  2. 2024
    Annual accounts 2024-15,8 k €↓
  3. 2023
    Annual accounts 2023-6,2 k €↓
  4. 2022
    Annual accounts 2022-3,8 k €↑
  5. 2021
    Annual accounts 2021-4 k €↓
  6. 2020
    Annual accounts 2020-2,9 k €↑
  7. 2019
    Annual accounts 2019-4,6 k €↑
  8. 2018
    Annual accounts 2018-4,7 k €↑
  9. 2017
    Annual accounts 2017-5 k €↓
  10. 2016
    Annual accounts 201646,2 k €↑
  11. 2015
    Annual accounts 201523,7 k €↑
  12. 2014
    Annual accounts 201410,1 k €↑
  13. 2013
    Annual accounts 2013-31,6 k €↓
  14. 2012
    Annual accounts 20122,4 k €↓
  15. 2011
    Annual accounts 201167,8 k €↑
  16. 2010
    Annual accounts 2010-3,9 k €↓
  17. 2009
    Annual accounts 2009-2,8 k €↓
  18. 2009
    Name changePHENIX PROPERTY
  19. 2008
    Annual accounts 20083,2 k €↓
  20. 2007
    Annual accounts 200730,9 k €↑
  21. 2006
    Annual accounts 2006-47,9 k €
  22. 30/10/1973
    IncorporationPublic limited company